Park, Jeongho
Wang, Qin
Wu, Qi
Mao-Draayer, Yang
Kim, Chang H.
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (UM1-AI110557, R01DK076616, R01AI080769)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01-NS080821)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI121302)
National Multiple Sclerosis Society (RG 4715-A-1)
Article History
Received: 21 February 2019
Accepted: 31 May 2019
First Online: 20 June 2019
Change Date: 20 November 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing Interests
: Y.M.D. has served as a consultant and/or received grant support from: Acorda, Bayer Pharmaceutical, Biogen Idec, Celgene, EMD Serono, Sanofi-Genzyme, Novartis, Questor, and Teva Neuroscience. Other authors declare no financial or commercial conflicts of interest.